Consolidated Statements of Operations (Unaudited) (USD $) Share data in Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	$ 333,196	$ 526,558	$ 690,537	$ 1,631,562
Depreciation	127,159	244,307	312,043	490,303
Research and development (including stock-based compensation (Note 8))	104,237	(120,003)	170,823	(53,445)
Total operating expenses	564,592	650,862	1,173,403	2,068,420
Loss from operations	(564,592)	(650,862)	(1,173,403)	(2,068,420)
Other expense:
Interest expense	100,356	88,606	197,303	174,717
Other expense				1,918
	100,356	88,606	197,303	176,635
Net loss	(664,948)	(739,468)	(1,370,706)	(2,245,055)
Net loss attributable to the noncontrolling interest	1,028	1,444	2,099	2,738
Net loss attributable to Bion	(663,920)	(738,024)	(1,368,607)	(2,242,317)
Dividends on preferred stock	(500)	(500)	(1,000)	(1,000)
Net loss applicable to Bion's common stockholders	$ (664,420)	$ (738,524)	$ (1,369,607)	$ (2,243,317)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.03)	$ (0.04)	$ (0.07)	$ (0.12)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	19,965,459	18,405,229	19,891,267	18,230,127